Are We Measuring Metabolic Health All Wrong?
A fragmented system built on isolated metrics like BMI and A1C fails to capture the full picture of metabolic health and limits our ability to manage it effectively.
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Report: How Employers Can Better Manage GLP-1s for Adolescents
A new Nomi Health report found that GLP-1 use and spending among adolescents rose sharply from 2022 to 2025, raising concerns about future costs for self-insured employers.
Why Metabolic Health Is a Common Thread Across Diabetes, Heart Disease, and Some Cancer
A common mechanism for reversing metabolic disease in some patients seems to be the sustained flattening of the hills and valleys of glucose and insulin.
AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds
AstraZeneca’s deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly’s obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies.
The CGM Adoption Gap Is Worse Than You Think
A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
HealthTap Joins LillyDirect to Expand Access to Primary Care–Led Diabetes Treatment
HealthTap is now offering virtual primary care for patients with diabetes on LillyDirect, becoming the platform’s first primary care provider.
Over-the-Counter CGMs Are Here — But Do They Really Make Sense for Non-Diabetics?
Over-the-counter continuous glucose monitors have been available for people with and without diabetes for more than a year now — but the data they collect doesn’t seem to be as useful for nondiabetic users, according to new research from Mass General Brigham.
The Future of Glucose Monitoring: Why Blood-Based Measurements Matter
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations.
Priority Health Teams Up with Virta Health for Diabetes, Weight Loss Support
Priority Health has partnered with Virta Health to offer a suite of diabetes and weight management solutions to its employer clients.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Why Is Medtronic Spinning Off Its Diabetes Business?
Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.
Aeroflow Health Unveils New Diabetes Management Program
Aeroflow Health has launched a new diabetes program that offers educational content on diabetes management, medical nutrition therapy and more.
The Role of Medication Delivery in Non-Adherence
For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023.
Prioritizing CKD Screening Guidelines is Imperative to Combat Global Health Crisis
The consequences for not prioritizing new guidelines for CKD screening have a devastating impact on population health by increasing the global mortality rate and driving higher healthcare costs.